High Intensity Resistance Training With and Without Blood Flow Restriction in ACL Reconstruction
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 9, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of high-intensity resistance training on athletes recovering from anterior cruciate ligament (ACL) reconstruction surgery. Specifically, it aims to compare two training methods: one group will do traditional high-intensity exercises without any special equipment, while the other group will use a technique called blood flow restriction, which involves applying a band to the limb to reduce blood flow during exercise. The goal is to see which method helps athletes recover better and faster after their surgery.
To participate in this study, you must be a male athlete aged between 18 and 25 who is in the later stages of rehabilitation after a grade III ACL tear. You should have been actively playing sports for at least two years. Participants will be randomly assigned to one of the two training groups, and everyone in the study will be monitored closely to ensure safety and effectiveness. This trial is currently looking for volunteers, so if you meet the criteria and are interested in helping advance recovery methods for athletes, this could be a great opportunity!
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male players with age group 18 to 25 years,Return to function phase of rehabilitation,Players with Grade III ACL Tear ,Athletes who have been playing for at least 2 years
- Exclusion Criteria:
- • Players after ACL Reconstruction in acute or subacute phase,Players with other biomechanical issues of knee or feet,Players with any hematological disorders or hypertension
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Muhammad Nouman Tabassum, DPT
Principal Investigator
Ghurki Trust & Teaching Hospital,Lahore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported